Skip to main content

Table 1 Demographics and baseline clinical characteristics of the SABINA III Gulf cluster cohort

From: Over-prescription of short-acting β2-agonists and asthma management in the Gulf region: a multicountry observational study

 

All

(N = 301)

Primary care physicians (n = 135)

Respiratory specialists (n = 162)

Mild asthma

(n = 32)

Moderate-to-severe asthma (n = 103)

All (n = 135)

Mild asthma

(n = 13)

Moderate-to-severe asthma

(n = 149)

All

(n = 162)

Age, years

 Mean (SD)

43.9 (15.3)

39.0 (14.9)

46.8 (15.7)

45.0 (15.8)

39.5 (7.9)

43.6 (15.3)

43.2 (14.9)

 Median (min, max)

43.0 (12.0, 82.0)

40.5 (14.0, 71.0)

45.0 (12.0, 82.0)

45.0 (12.0, 82.0)

40.0 (23.0, 56.0)

44.0 (13.0, 74.0)

42.0 (13.0, 74.0)

Age group, years, n (%)

 12–17

18 (6.0)

3 (9.4)

5 (4.9)

8 (5.9)

0 (0)

10 (6.7)

10 (6.2)

 18–54

205 (68.1)

25 (78.1)

68 (66)

93 (68.9)

12 (92.3)

96 (64.4)

108 (66.7)

  ≥ 55

78 (25.9)

4 (12.5)

30 (29.1)

34 (25.2)

1 (7.7)

43 (28.9)

44 (27.2)

Sex, n (%)

 Female

186 (61.8)

25 (78.1)

64 (62.1)

89 (65.9)

10 (76.9)

86 (57.7)

96 (59.3)

BMI, kg/m2

 Mean (SD)

30.2 (6.2)

31.5 (7.6)

30.2 (6.4)

30.5 (6.7)

30.1 (7.7)

29.8 (5.6)

29.9 (5.7)

 Median (min, max)

29.4 (18.2, 53.9)

29.9 (21.2, 53.9)

29.1 (19.0, 52.3)

29.4 (19.0, 53.9)

29.9 (20.7, 47.1)

29.4 (18.2, 48.1)

29.4 (18.2, 48.1)

BMI group, kg/m2, n (%)

  < 18.5

2 (0.7)

0 (0)

0 (0)

0 (0)

0 (0)

2 (1.3)

2 (1.2)

  ≥ 18.5–24.9

54 (17.9)

6 (18.8)

22 (21.4)

28 (20.7)

3 (23.1)

23 (15.4)

26 (16)

  ≥ 25–29.9

107 (35.5)

10 (31.2)

35 (34)

45 (33.3)

4 (30.8)

56 (37.6)

60 (37)

  ≥ 30

138 (45.8)

16 (50)

46 (44.7)

62 (45.9)

6 (46.2)

68 (45.6)

74 (45.7)

Education level, n (%)

 Primary or secondary school

85 (28.2)

8 (25)

28 (27.2)

36 (26.7)

0 (0)

48 (32.2)

48 (29.6)

 High school

73 (24.3)

4 (12.5)

30 (29.1)

34 (25.2)

6 (46.2)

33 (22.1)

39 (24.1)

 University and/or post-graduate education

107 (35.5)

12 (37.5)

23 (22.3)

35 (25.9)

7 (53.8)

62 (41.6)

69 (42.6)

 Unknown

36 (12)

8 (25)

22 (21.4)

30 (22.2)

0 (0)

6 (4)

6 (3.7)

Healthcare insurance/medication funding, n (%)

 Not reimbursed

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

 Partially reimbursed

12 (4)

5 (15.6)

3 (2.9)

8 (5.9)

1 (7.7)

3 (2)

4 (2.5)

 Fully reimbursed

287 (95.7)

27 (84.4)

99 (96.1)

126 (93.3)

12 (92.3)

145 (98)

157 (97.5)

 Unknown

1 (0.3)

0 (0)

1 (1)

1 (0.7)

0 (0)

0 (0)

0 (0)

 Missing values, n

1

0

0

0

0

1

1

Smoking status history, n (%)

 Active smoker

28 (9.3)

3 (9.4)

11 (10.7)

14 (10.4)

0 (0)

14 (9.4)

14 (8.6)

 Former smoker

15 (5)

0 (0)

4 (3.9)

4 (3)

0 (0)

11 (7.4)

11 (6.8)

 Never smoker

258 (85.7)

29 (90.6)

88 (85.4)

117 (86.7)

13 (100)

124 (83.2)

137 (84.6)

  1. Prescriber type was not recorded for two patients each in mild asthma and moderate-to-severe asthma group
  2. Abbreviations: BMI body mass index, max maximum, min minimum, SABINA SABA use IN Asthma, SD standard deviation